Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Independence Blue Cross	Mirvetuximab soravtansine-gynx (Elahere)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-159	New policy
Aug 2, 2026	Independence Blue Cross	Mirikizumab-mrkz (Omvoh) for Intravenous UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-169	New policy
Aug 2, 2026	Independence Blue Cross	Migraine Deactivation SurgeryPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-098	New policy
Aug 2, 2026	Independence Blue Cross	Mentoplasty or GenioplastyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-080	New policy
Aug 2, 2026	Independence Blue Cross	Medicare Part B vs. Part D Crossover DrugsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-007AW-37ED65726B	New policy
Aug 2, 2026	Independence Blue Cross	Medical NecessityPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA12-008	New policy
Aug 2, 2026	Independence Blue Cross	Medical and Surgical Treatment of Temporomandibular Joint DisorderPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-024	New policy
Aug 2, 2026	Independence Blue Cross	Mechanical Stretching Devices for the Treatment of Joint Stiffness or ContracturesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-043	New policy
Aug 2, 2026	Independence Blue Cross	Measurement of Serum Antibodies to and Measurement of Serum Levels of BiologicsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-019	New policy
Aug 2, 2026	Independence Blue Cross	Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory DisordersPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-044	New policy
Aug 2, 2026	Independence Blue Cross	Marijuana for Medical UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-038	New policy
Aug 2, 2026	Independence Blue Cross	Margetuximab-cmkb (Margenza)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-132	New policy
Aug 2, 2026	Independence Blue Cross	Manual WheelchairsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-026	New policy
Aug 2, 2026	Independence Blue Cross	Manipulation Under AnesthesiaPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-091	New policy
Aug 2, 2026	Independence Blue Cross	Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound AblationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA09-021	New policy
Aug 2, 2026	Independence Blue Cross	Magnetic Resonance Imaging (MRI) Contrast AgentsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA09-010	New policy
Aug 2, 2026	Independence Blue Cross	Magnetic Pelvic Floor Stimulation (MPFS)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-014	New policy
Aug 2, 2026	Independence Blue Cross	Lyme Disease: Diagnosis and Intravenous (IV) Antibiotic TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-006	New policy
Aug 2, 2026	Independence Blue Cross	Luspatercept–aamt (Reblozyl)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-110	New policy
Aug 2, 2026	Independence Blue Cross	Lurbinectedin (Zepzelca)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-125	New policy
Aug 2, 2026	Independence Blue Cross	Lumasiran (Oxlumo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-131	New policy
Aug 2, 2026	Independence Blue Cross	Low Osmolar Contrast AgentsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA09-008	New policy
Aug 2, 2026	Independence Blue Cross	Low-Level Laser TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-036	New policy
Aug 2, 2026	Independence Blue Cross	Lower Limb ProsthesesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-024	New policy
Aug 2, 2026	Independence Blue Cross	Loncastuximab tesirine-lpyl (Zynlonta)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-139	New policy
Aug 2, 2026	Independence Blue Cross	Lipectomy and LiposuctionPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-070	New policy
Aug 2, 2026	Independence Blue Cross	Linvoseltamab-gcpt (Lynozyfic)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-188	New policy
Aug 2, 2026	Independence Blue Cross	Lifileucel (Amtagvi)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-172	New policy
Aug 2, 2026	Independence Blue Cross	Level of Care for Elective Procedures (Hospital Inpatient to Hospital Outpatient Level of Care)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA12-012	New policy
Aug 2, 2026	Independence Blue Cross	Leuprolide (Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron Depot)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-083	New policy
Aug 2, 2026	Independence Blue Cross	Leadless PacemakersPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-067	New policy
Aug 2, 2026	Independence Blue Cross	Laser Interstitial Thermal Therapy (LITT)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-034	New policy
Aug 2, 2026	Independence Blue Cross	Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid MyolysisPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-116	New policy
Aug 2, 2026	Independence Blue Cross	Lanreotide (Somatuline Depot)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-090	New policy
Aug 2, 2026	Independence Blue Cross	Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) ProductsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-030AK-AC83E9683E	New policy
Aug 2, 2026	Independence Blue Cross	LabiaplastyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-067	New policy
Aug 2, 2026	Independence Blue Cross	Knee OrthosesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-013	New policy
Aug 2, 2026	Independence Blue Cross	Islet Cell Transplantation, including use of Donislecel-jujn (Lantidra)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-007	New policy
Aug 2, 2026	Independence Blue Cross	Isatuximab-irfc (Sarclisa)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-117	New policy
Aug 2, 2026	Independence Blue Cross	Ipilimumab (Yervoy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-059	New policy
Aug 2, 2026	Independence Blue Cross	In Vivo Allergy Sensitivity TestingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-004	New policy
Aug 2, 2026	Independence Blue Cross	In Vitro Chemosensitivity and Chemoresistance AssaysPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-021	New policy
Aug 2, 2026	Independence Blue Cross	In Vitro Allergy TestingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-002	New policy
Aug 2, 2026	Independence Blue Cross	Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) InhibitorsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-073	New policy
Aug 2, 2026	Independence Blue Cross	Intravenous Ketamine (Ketalar) and Intranasal Esketamine (Spravato)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-137	New policy
Aug 2, 2026	Independence Blue Cross	Intravenous Infliximab and Related BiosimilarsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-019	New policy
Aug 2, 2026	Independence Blue Cross	Intravenous Chelation TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-016	New policy
Aug 2, 2026	Independence Blue Cross	Intravenous (IV) Iron PreparationsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-150	New policy
Aug 2, 2026	Independence Blue Cross	Intravenous (IV) Administration of Fluids as a Treatment of a Medical Condition or for the Preparation of Pharmaceuticals, Biologics, and other SubstancesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-022	New policy
Aug 2, 2026	Independence Blue Cross	Intrauterine Systems (IUSs) (e.g., Mirena, Skyla, Liletta, Kyleena)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-025	New policy